Table 1

Baseline demographic and laboratory profiles

RepairReplacementp Value
Number of patients39752
Age, years56.4±12.354.6±12.70.32
Male gender, n (%)137 (34.5)15 (28.8)0.42
Diabetes mellitus, n (%)28 (7.1)5 (9.6)0.57
Hypertension, n (%)59 (14.9)6 (11.5)0.68
Atrial fibrillation, n (%)322 (81.1)30 (57.7)<0.001
 Maze procedure, n (%)134 (33.8)4 (7.7)<0.001
History of thromboembolic events, n (%)38 (9.6)2 (3.8)0.17
 Stroke, n (%)35 (8.8)2 (3.8)0.29
 Other peripheral thromboembolism, n (%)3 (0.8)0>0.99
Liver cirrhosis, n (%)13 (3.3)00.38
Chronic pulmonary disease, n (%)9 (2.3)3 (5.8)0.15
On dialysis, n (%)5 (1.3)0>0.99
Coronary disease, n (%)15 (3.8)00.24
NYHA functional class, n (%)0.67
 I57 (14.4)9 (17.3)
 II152 (38.3)18 (34.6)
 III139 (35.0)16 (30.8)
 IV49 (12.3)9 (17.3)
Previous cardiac surgery, n (%)47 (11.8)18 (34.6)<0.001
 Aortic valve3 (0.8)2 (3.8)0.11
 Mitral valve33 (8.3)8 (15.4)0.12
 Aortic+mitral valve10 (2.5)5 (9.6)0.21
 Others1 (0.3)4 (7.7)0.001
Laboratory findings
 Leukocyte count,/mm36070±20795851±30180.62
 Haemoglobin, g/dl12.5±2.111.6±2.00.005
 Platelet count, 1000/mm3184.4±67.1169.9±62.40.14
 Albumin, g/dl3.81±0.463.77±0.550.53
 Creatine, mg/dl1.00±0.490.98±0.610.72
 eGFR, ml/min/1.73 m272.6±23.473.9±19.40.68
 Bilirubin, mg/dl1.34±0.771.89±3.210.22
 B-type natriuretic peptide, pg/ml787.2±320.0587.4±373.10.81
  • eGFR, estimated glomerular filtration rate; NYHA, New York Heart Association.